Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-081091

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 6:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 16, 2015M1,549$0.00A93,465D
Common StockF1Nov 16, 2015M817$0.00A94,282D
Common StockNov 17, 2015S1,184$31.10D93,098D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Nov 16, 2015M1,549D——Common Stock1,54913,936D
Restricted Stock UnitsF3,F6,F7—Nov 16, 2015M817D——Common Stock8177,900D

Explanation of responses